# Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma

> **NCT00006024** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 32 (actual)

## Conditions studied

- Brain Tumor
- Central Nervous System Tumor

## Interventions

- **DRUG:** lomustine
- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00006024
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2005-01
- **Final completion:** 2006-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006024, "Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00006024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*